Infections with the sexually transmitted protozoan Trichomonas vaginalis are usually treated with metronidazole, a 5-nitroimidazole drug derived from the antibiotic azomycin. Metronidazole treatment is generally efficient in eliminating T. vaginalis infection and has a low risk of serious side effects. However, studies have shown that at least 5% of clinical cases of trichomoniasis are caused b...

Trichomonas vaginalis (T. vaginalis) is one of the most prevalent, non-viral protozoan pathogens and the most common sexually transmitted organism in females, yet it is one of the least investigated infectious agents. An estimate of around 180 million new infections is found worldwide every year[1,2]. The high T. vaginalis prevalence worldwide is concentrated in developing countries and socioec...

Both the literature and personal investigations (Popchristov, 1957) indicate beyond any doubt that the relative percentage of urethritis and vaginitis due to Trichomonas vaginalis rises with increased rates of non-gonococcal genital infections. Of 278 patients with non-gonococcal urethritis and colpitis, and 102 patients with gonorrhoea seen at the Dispensary of the Institute for Skin and Vener...

Background. Trichomoniasis is a common sexually transmitted disease caused by Trichomonas vaginalis. It is a major health problem worldwide. The World Health Organization (WHO) has estimated that 180 million infections are acquired annually worldwide. Methodology. Vaginal swabs (1207) were cultured for T. vaginalis on Trichomonas Medium no. 2 (Oxoid) soon after specimen collection. The cultures...

Broth culture of Trichomonas vaginalis is considered the "gold standard" for the diagnosis of trichomoniasis. Two studies were carried out to evaluate modified Columbia agar (MCA) for the isolation of T. vaginalis from clinical samples. Study I compared isolation on MCA to that on liquid medium with 889 vaginal samples. Out of 63 samples positive for T. vaginalis (7.1% of total), MCA identified...

background: trichomonas vaginalis is a parasitic protozoan with a predilection for human urogenital tract and causative agent for vaginitis, cervicitis and urethritis in females. t. vaginalis is known as a cofactor in transmission of human immunodeficiency virus and may lead to adverse outcomes in pregnant women. the goal of this study was to determine the prevalence of t. vaginalis infection i...

Background and aims: Trichomoniasis is the most common non-viral sexually transmitted infection worldwide; although it treated by a 5-nitroimidazole drug family such as metronidazole (MTZ) with numerous side effects, in this regard, alternative new drugs are required. Therefore, study examined anti-Trichomoniasis effect of hydroalcoholic extract some traditional medicinal plants Iran vitro. Met...

OBJECTIVES To measure the prevalence of urethral infections including trichomoniasis in rural Tanzanian men, to assess the prevalence of symptoms and signs among men with Trichomonas vaginalis, and to analyse the risk factors for trichomoniasis. DESIGN A cross sectional study of 1004 men aged 15-54 years in a rural community in north west Tanzania. METHODS Participants were interviewed abou...

Trichomoniasis is the most common non-viral sexually transmitted infection, and it is caused by the protozoan flagellate Trichomonas vaginalis. Although highly prevalent in sexually active women, it has long been overlooked in other groups of potentially infected people. Recently, studies have shown that trichomoniasis increases the risk of infection with human immunodeficiency virus and can ca...